LFST:NSD-Lifestance Health Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 7.91

Change

0.00 (0.00)%

Market Cap

USD 3.03B

Volume

0.47M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-09 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-1.77 (-1.35%)

USD 8.00B
OPCH Option Care Health Inc

+0.37 (+1.19%)

USD 5.27B
ACHC Acadia Healthcare Company Inc

+0.89 (+2.12%)

USD 4.19B
SGRY Surgery Partners Inc

-0.22 (-0.85%)

USD 3.24B
AMED Amedisys Inc

+0.05 (+0.05%)

USD 3.03B
ADUS Addus HomeCare Corporation

+0.36 (+0.31%)

USD 2.27B
ASTH Astrana Health Inc

+0.95 (+2.66%)

USD 1.68B
AVAH Aveanna Healthcare Holdings In..

+0.09 (+1.93%)

USD 0.89B
HCSG Healthcare Services Group Inc

-0.08 (-0.74%)

USD 0.83B
CCRN Cross Country Healthcare Inc

+0.02 (+0.11%)

USD 0.59B

ETFs Containing LFST

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.33% 67% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.33% 67% D+ 75% C
Trailing 12 Months  
Capital Gain 19.13% 81% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.13% 81% B- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.90% 46% F 23% F
Dividend Return -7.90% 46% F 23% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.90% 65% D 60% D-
Risk Adjusted Return -25.57% 46% F 21% F
Market Capitalization 3.03B 79% B- 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.